搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Armed robbery in Revesby
1 天
Recording Cancer Cells From Inside
On the wall of Dian Yang's office hangs a painting of a "Pandora's box of cancer" being opened with a molecular key. From ...
2 天
Bio-Path Holdings, Inc.: Bio-Path Holdings Reports Third Quarter 2024 Financial Results
Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotech ...
Knowridge
2 天
How DNA changes from lifestyle choices cause cancer
Certain types of cancer are common in the United States and are often influenced by lifestyle choices. For example, skin ...
Vietnam Investment Reviev
2 天
I-Mab Reports Third Quarter 2024 Results
I-Mab, a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies ...
EurekAlert!
2 天
New microfluidic device reveals how the shape of a tumour can predict a cancer’s ...
Researchers at the University of Toronto’s Faculty of Applied Science & Engineering have designed a new microfluidic platform ...
2 天
New RAS Gene Discovery Unveils Hidden Pathway Driving Cancer Growth
These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...
FierceBiotech
3 天
Sensei Bio lays off 46% of staff, closes research site to fund phase 2 cancer trial
Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...
biopharma-reporter
3 天
Alentis raises $181 million to advance ADCs to the clinic
The Series D financing will support the clinical development of two ADCs.
Brantford Expositor
3 天
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company exploring new pathways towards a ...
manilatimes
4 天
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
Acrivon Therapeutics, Inc. ("Acrivon” or "Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage precision medicine company ...
ThePrint
4 天
India hosts BIMSTEC countries for annual National Cancer Grid meeting in Mumbai
India hosted senior cancer physicians and policymakers from the Bay of Bengal Initiative for Multi-Sectoral Technical and ...
4 天
Contradictory Discovery: Our Innate Immune System May Fuel Cancer Development
MSK researchers discovered that the innate immune system's chronic activation due to issues in the Mre11 complex can lead to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈